Chronic kidney disease trials in Australia

In Australia 20 Also abroad 798

20 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Adelaide, Darlinghurst, Elizabeth Vale, Gosford, North Tamworth, Perth, Southport, St Leonards, Wollongong
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Adelaide, Blacktown, Box Hill, Brisbane, Camberwell, Deakin, Frankston, Garran, Geelong, Ipswich, Norwood, Sippy Downs, South Brisbane, Sydney, Waitara
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
Phase 2Taking people
Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
Where
Brisbane, Gosford, Newcastle
Age
18 years to 75 years
People
80 worldwide
Run by
Atom Therapeutics Co., Ltd
See details and how to joinNCT07323095
No phaseEnrolling by invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Canberra, Melbourne, North Sydney, Perth, Sydney
Age
0 Minutes to 2 weeks
People
8,000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
Phase 1Not yet taking people in Australia
Study of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease
Where
Gosford, Perth, Southport, St Leonards
Age
18 years to 75 years
People
24
Run by
Cajal Therapeutics Inc.
See details and how to joinNCT07901933
No phaseTaking people
SPYRAL GEMINI Pilot Study
Where
Perth
Age
18 years to 80 years
People
175 worldwide
Run by
Medtronic Vascular
See details and how to joinNCT06907147
No phaseTaking people
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
Where
Melbourne, Perth
Age
18 years and over
People
130 worldwide
Run by
Medtronic Vascular
See details and how to joinNCT07115953
Phase 2Taking people
Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
Where
Adelaide, Frankston, Melbourne, Mulgrave
Age
18 years to 80 years
People
180 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07830719 · EU 2026-525974-21-00
Phase 1/2Taking people
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
Where
Gosford, Herston, Morayfield, Saint Albans, Sydney
Age
18 years to 75 years
People
94 worldwide
Run by
Ingenia Therapeutics INC
See details and how to joinNCT07231679
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Adelaide, Parkville, Woolloongabba
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 3Taking people
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Where
Adelaide, Birtinya, Douglas, Elizabeth Vale, Garran, Heidelberg, Ipswich, Kingswood, Kogarah, Murdoch, New Lambton Heights, Southport, Westmead
Age
18 years and over
People
2,000 worldwide
Run by
The George Institute
See details and how to joinNCT06058585 · EU 2024-520253-21-00
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Clayton, Parkville, South Brisbane
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Bundaberg, Cairns, Clayton, Heidelberg, Liverpool, Murdoch, Nambour, Parkville, Saint Leonards, Southport, St Albans, Sydney, Urraween, Wahroonga, Westmead, Wollongong, Woolloongabba
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Castle Hill, Fitzroy, Gosford, Melbourne, Perth, Southport, St Leonards, Wollongong, Woolloongabba
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
No phaseTaking people
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
Where
Adelaide, Armadale, Bedford Park, Birtinya, Brisbane, Bundaberg, Cairns, Camperdown, Heidelberg, Hervey Bay, Kingswood, Kogarah, Mackay, Meadowbrook, Melbourne, Saint Leonards, Southport, Townsville, Traralgon, Westmead, Wollongong
Age
18 years and over
People
3,600 worldwide
Run by
The University of Queensland
See details and how to joinNCT03573089
No phaseTaking people
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
Where
Bedford Park
Age
18 years and over
People
220 worldwide
Run by
C. R. Bard
See details and how to joinNCT04634916
Phase 1Taking people
Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
Where
Melbourne
Age
18 years to 65 years
People
88
Run by
Mediar Therapeutics
See details and how to joinNCT07473323
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Castle Hill, Chelmer, Gosford, Reservoir, St Albans
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00
Phase 1/2Taking people
A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease
Where
Botany, Camberwell, Kotara
Age
18 years to 75 years
People
60 worldwide
Run by
Intelligem Therapeutics Australia Pty Ltd.
See details and how to joinNCT06310967
Phase 4Taking people
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Where
Adelaide, Auburn, Bedford Park, Bentleigh East, Birtinya, Brisbane, Bundaberg, Caloundra, Camperdown, Canberra, Frankston, Gympie, Ipswich, Mackay, Meadowbrook, Melbourne, Nambour, Northfield, Pialba, St Leonards, Sunshine Coast, Sydney, Woodville South
Age
18 years and over
People
50,000 worldwide
Run by
University of Sydney
See details and how to joinNCT02823821